Home
About us
Editorial board
Ahead of print
Browse Articles
Search
Submit article
Instructions
Subscribe
Contacts
Login
Advanced Search
Users Online: 1364
» Articles published in the past year
To view other articles click corresponding year from the navigation links on the left side.
All
|
Case Report
|
Case Reports
|
Editorial
|
Erratum
|
Letter To Editor
|
Letters to Editor
|
Mini Review
|
Notice of Retraction
|
Original Article
|
Original Articles
|
Review Article
|
Review Articles
|
Short Communication
|
Short Communications
|
Systematic Review
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Short Communication:
Molecular identification and antifungal susceptibility profile of
Candida
species isolated from patients with vulvovaginitis in Tehran, Iran
Somayeh Sharifynia, Mehraban Falahati, Lame Akhlaghi, Alireza Foroumadi, Roohollah Fateh
J Res Med Sci
2017, 22:132 (26 December 2017)
DOI
:10.4103/jrms.JRMS_106_17
PMID
:29387119
Background:
Rapid and accurate identification and evaluation of antifungal susceptibility pattern of
Candida
isolates are crucial to determine suitable antifungal drugs for the treatment of patients with vulvovaginitis candidiasis.
Materials and Methods:
Vaginal samples were collected from 150 women with suspicious vaginal candidiasis, and then cultured on Sabouraoud's Dextrose Agar with chloramphenicol to isolate
Candida
species. After identification of
Candida
isolates using polymerase chain reaction-restriction fragment length polymorphism technique, antifungal susceptibility testing of four azolic antifungal drugs was carried out using broth microdilution method according to the CLSI M27-A3.
Results:
Candida
species were isolated from eighty suspected patients (61.79%). The most common pathogen was
Candida albicans
(63.75%). Resistance to fluconazole and ketoconazole was observed in 27.5% and 23.75% of
Candida
isolates, respectively, and only 2% of
Candida
isolates were resistant to miconazole. Interestingly, resistance to fluconazole in
C. albicans
was more than other
Candida
species.
Conclusion:
The results indicated that therapy should be selected according to the antifungal susceptibility tests for the prevention of treatment failure and miconazole therapy can be considered as the best therapeutic choice in the management of vulvovaginitis.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (4) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Short Communication:
Appropriate blood component therapy can reduce postcardiac surgery acute kidney injury through packed cell transfusion reduction
Kianoush Saberi, Mehrdad Salehi, Mehrzad Rahmanian, Ali Reza Bakhshandeh, Gholam Reza Massoumi
J Res Med Sci
2017, 22:80 (21 June 2017)
DOI
:10.4103/jrms.JRMS_910_15
PMID
:28717377
Background:
Acute kidney injury (AKI) can happen due to different factors such as anemia. Packed cell (PC) transfusion is an important cause of AKI occurrence. The aim of the study is to investigate whether appropriate blood component (BC) therapy can reduce blood transfusion and it would result in AKI decreasing.
Materials and Methods:
We conducted a cohort study of 1388 patients who underwent cardiac surgery in one university hospital. A serum creatinine higher than 2 mg/dl, renal disease history, renal replacement therapy (chronic dialysis) were our exclusion criteria.
Results
: from our 1088 samples, 701 (64.43%) patients had normal kidney function, 277 (25.45%) were in the AKI-1 group, 84 (7.72%) had an AKI-2 function, and the rest of patients were classified as end stage. A mean of more than three PC units were transfused for the second and third stage of AKI, which was significantly higher than other AKI groups (
P
= 0.009); this higher demand of blood product was also true about the fresh frozen plasma, platelet, and fibrinogen. However, there were no needs of fibrinogen in the patients with normal kidney function. The cardiopulmonary bypass time had an average of 142 ± 24.12, which obviously was higher than other groups (
P
= 0.032). Total mortality rate was 14 out of 1088 (1.28%), and expiration among the AKI stages 2 and 3 was meaningfully (
P
= 0.001) more than the other groups.
Conclusion:
A more occurrence of AKI reported for the patients who have taken more units of blood. However, BC indicated to be safer for compensating blood loss because of low AKI occurrence among our patients.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Advanced Search
Month wise articles
Figures next to the month indicate the number of articles in that month
2023
May
[
1
]
April
[
3
]
February
[
2
]
2022
October
[
1
]
September
[
1
]
August
[
1
]
July
[
1
]
June
[
2
]
May
[
1
]
April
[
1
]
February
[
1
]
2021
November
[
2
]
September
[
3
]
July
[
2
]
June
[
1
]
2020
September
[
1
]
May
[
1
]
March
[
1
]
February
[
3
]
2019
December
[
1
]
August
[
1
]
June
[
1
]
April
[
1
]
March
[
1
]
February
[
1
]
January
[
1
]
2018
November
[
2
]
October
[
2
]
September
[
1
]
March
[
1
]
2017
December
[
1
]
June
[
1
]
Sitemap
|
What's New
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
© Journal of Research in Medical Sciences | Published by Wolters Kluwer -
Medknow
Online since 9
th
February, 2015